Form 8-K TANDEM DIABETES CARE For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tandem Diabetes Care (TNDM) PT Lowered to $51 at Barclays
August 7, 2025 8:27 AM EDTBarclays analyst Matt Miksic lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $51.00 (from $53.00) while maintaining a Overweight rating.
The analyst comments "Q2 sales were a touch above consensus, with upside OUS offset by a shortfall in the U.S. Mgmt... More
